MAPKs, markers of inflammation which also drive proliferation of cancer cells [31], were not affected much, as JNK activation was unaffected and only phosphorylation of p38 was decreased in cancer tissues of VA-treated mice. This evidence concerns the gene MAPK8 and cancer.